Zolantidine
Zolantidine is a brain-penetrating selective histamine H 2 receptor (HRH 2 ) antagonist developed by Smith, Kline & French, with the research code of SK&F 95282.
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Zolantidine is a brain-penetrating selective histamine H 2 receptor (HRH 2 ) antagonist developed by Smith, Kline & French, with the research code of SK&F 95282. It is a benzothiazole derivative with a 30-fold higher potency for H 2 receptors than other peripheral and central receptors.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1332233840 under CC BY-SA 4.0; modifications have been made.